Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
ELTX4 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in ELICIO THERAPEUTICS INC
No. Balyasny Asset Management exited its ELTX (Elicio Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 244,814 shares worth $2.6M. Balyasny Asset Management first reported ELTX in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.6M
Total Shares Change
-148,076
Quarter-by-Quarter History
Other major holders of ELTX: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc.